Abstract:Aim: To observe the changes of serum interleukin-8, monocyte chemoattractant protein-1and interleukin-10 in patients with obstructive sleep apnea hypopnea syndrome (OSAHS), and to explore the significance. Methods: Thirty-five patients with obstructive sleep apnea hypopnea syndrome confirmed by polysomnography, who hospitalized in Department of Respiratory Medicine, First Hospital of Lanzhou University from December 2002 to December 2003, were selected. Ten with moderate and severe OSAHS of these patients had been treated by nasal continuous positive air pressure for over half a year, were selected as treatment group aged (51 ±13) years old. The included patients all knew the fact of the treatment program and agreed. Twenty-five healthy subjects in this hospital were recruited as the control group during the same period, and agreed to take part in the experiment. The apnea hypopnea index and lowest blood oxygen saturation were detected by the Polywin polysomnography. The serum levels of interleukin-8, interleukin-10 and monocyte chemoattractant protein-1 were measured by enzyme linked immune sandwich assay. The patients with moderate and severe OSAHS were treated with continuous positive airway. The pressure of nasal continuous positive airway was 0.588-1.176 kPa for 6-8 hours every day. The t-test was performed among the comparison of groups, and the paired t-test was conducted among the comparison within the groups. The correlation check among indexes was done by linear correlation analysis. Results: Before treatment the number of people kept the upper number, and after treatment 10 patients with moderate and severe OSAHS and 25 healthy people were involved in the result analysis. 1 The serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with OSAHS (35 cases) were significantly higher than those in the control group (t=5.498, 9.626, P < 0.01), and the level of serum interleukin-10 was lower obviously than that in the control group (t=-4.667,P < 0.01). 2 The levels of serum interleukin-8 and monocyte chemoattractant protein-1 in patients with OSAHS had significantly positive correlation with apnea hypopnea index (r=0.671, 0.742, P < 0.01), and had negative correlation with lowest blood oxygen saturation (r=-0.442, -0.531, P < -0.01).The level of serum interleukin-10 had significantly negative correlation with apnea hypopnea index (r=-0.688, P < 0.01), and had positive correlation with lowest blood oxygen saturation (r=0.454, P < 0.01).3 The serum interleukin-10 and interleukin-8 had remarkably negative correlation with monocyte chemoatractant protein-1 (r=0.509, -0.666, P < 0.01), and the interleukin-8 had obviously positive correlation with monocyte chemoattractant protein-1 (r=0.706,P < 0.01). 4 The levels of serum in-terleukin-8 and monocyte chemoattractant protein-1 in patients of treat-ment group (10 cases)after half year treatment were lower significantly than those before treatment (t=4.896, 5.609, P < 0.01).The level of in-terleukin-10 was significantly higher than that before treatment (t=-4.625, P < 0.01). Conclusion: 1 The hypoxia induces the increase of serum interleukin-8 and monocyte chemoattractant protein-1, and the decrease of interleukin-10 in patients with OSAHS, which may join the occurrence of cardiovascular disease. 2 The nasal continuous positive airway treatment may reach the effect of preventing the occurrence of cardiovascular lesion in patients with OSAHS by means of relieving ischemia, decreasing the production of interleukin-8 and monocyte chemoattractant protein-1 and increasing the production of interleukin-10.

Expression of MMP-9 and TIMP-1 in soft palate of OSAHS patients

Expressions of MMP-8 and TIMP-1 in Gingival Tissue of Patients with Aggressive Periodontitis

Expressions of MMP-1,MMP-8 and MMP-13 in gingival tissue of patients with aggressive periodontitis

Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression in the soft palate of patients with obstructive sleep apnea hypopnea syndrome

The expression and correlation of MMP-9 and NF-κB in obstructive sleep apnea syndrome patients with hypertension

Serum Inflammatory Factors in Patients with Obstructive Sleep Apnea Syndrome and Coronary Heart Disease

Upregulation of HMGB1 promotes vascular dysfunction in the soft palate of patients with obstructive sleep apnea via the TLR4/NF‐κB/VEGF pathway

[Detection and Significance of CXCL8 and IL-10 in Serum and Tissue of the Patients' with OSAHS].

Matrix metalloproteinase 9 (MMP9) level and MMP9-1562C>T in patients with obstructive sleep apnea: a systematic review and meta-analysis of case-control studies

Expressions of substance P and vasoactive intestinal peptide in tongue base tissue of patients with obstructive sleep apnea-hypopnea syndrome and their significances

Plasma estrogen level and estrogen receptors expression in palatine tonsils in male patients with obstructive sleep apnea hypopnea syndrome

CT with 3D Reconstruction of Upper Respiratory Tract in Obstructive Sleep Apnea Hypopnea Syndrome Application

Matrix Metalloproteinase 9 (MMP9) Level and MMP9 -1562C>T in Patients with Obstructive Sleep Apnea: a Systematic Review and Meta-Analysis of Case-Control Studies.

Cough Hypersensitivity in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Changes of serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with obstructive sleep apnea hypopnea syndrome

Changes in Plasma Interleukin-18 and Monocyte Chemotaxis Protein-1 in Obstructive Sleep Apnea Syndrome and Their Significance

[Study of Cine-MRI for the Soft Palate in Patients with Obstructive Sleep Apnea Hypopnea Syndrome].

Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)

Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

[CD69 Expression on T Cell Surface in Patients with Obstructive Sleep Apnea Hypopnea Syndrome].